Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and Spatial Proteomics
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Webinar: Multimodal Assessment of Hypoxia in Tumors: From the Lab to the Clinic
Apr 2, 2024
25 April 2024, 4PM CET
This webinar will be of interest to multiple profiles in the community of biomedical...
Multiplexed tissue imaging using the Orion platform to reveal the Spatial Biology of Cancer
Mar 27, 2024
In this webinar Prof. Sandro Santagata, will reveal how Orion high-plex imaging and the use of this data, is valuable...
Improve your data resolution with Cytek Autofluorescence Extraction tool!
Feb 5, 2024
Samples with high autofluorescence (AF) can be difficult to resolve with conventional flow cytometry, especially if...
Webinar: transforming Calcium Flux analysis with Cytek Full Spectrum Profiling Technology
Jan 4, 2024
The research described in this webinar harnesses the innovative capabilities of FSP technology to perform advanced...
Webinar recording: BioFlux, the gold standard for Platelet Biology and Vascular Pharmacology studies
Jan 3, 2024
The BioFlux system give you the ability to introduce physiological shear flow to your research and drug discovery...
Integration of Full Spectrum Analysis and Cell Sorting technology to propel discovery
Dec 19, 2023
In this on-demand Cytek webinar, Dr. Maria Jaimes discusses the fundamentals of cell sorting, including cell recovery,...
Vizgen webinar recording: spatial relationships in Developmental Biology
Nov 21, 2023
MERFISH integrates spatial transcriptomics technology with high resolution spatial imaging, In this webinar we will...
Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST
Oct 13, 2016
Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).
Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
